Literature DB >> 25107452

Phospholipid transfer protein in diabetes, metabolic syndrome and obesity.

Shucun Qin, Guohua Song, Yang Yu1.   

Abstract

It has been reported that phospholipid transfer protein (PLTP) is an independent risk factor for human coronary artery disease. And metabolic tissues are important contributors to the systemic pools of PLTP protein. Consistently, PLTP mass and activity have been found to be elevated in the plasma of type 2 diabetes mellitus (T2DM) and obese patients. In this review, we summarized the recent progresses made in the PLTP research field and focused on the complexity of the implication of PLTP in obesity, insulin resistance and T2DM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25107452     DOI: 10.2174/1871529x1402140807144435

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  2 in total

1.  Human germline hedgehog pathway mutations predispose to fatty liver.

Authors:  Maria J Guillen-Sacoto; Ariel F Martinez; Yu Abe; Paul Kruszka; Karin Weiss; Joshua L Everson; Ramon Bataller; David E Kleiner; Jerrold M Ward; Kathleen K Sulik; Robert J Lipinski; Benjamin D Solomon; Maximilian Muenke
Journal:  J Hepatol       Date:  2017-06-21       Impact factor: 25.083

2.  Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses.

Authors:  Xiaoling Chen; Shufeng Wang; Yi Huang; Xia Zhao; Xu Jia; Gang Meng; Qian Zheng; Mengjun Zhang; Yuzhang Wu; Li Wang
Journal:  iScience       Date:  2020-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.